← All trials
NCT05753267
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 28, 2023
- Primary completion
- Feb 20, 2025
- Completion date
- Jun 20, 2025
- First posted
- Mar 3, 2023
- Last posted
- Mar 14, 2023
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Tanta UniversityLead sponsor
- Tanta UniversityReponsible party - principal investigator
- Menoufia UniversityCollaborator
- Tanta UniversitySponsor investigator
- Tanta UniversityCollaborator
- Tanta UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.